TSP160-DrugMatrix - Toxicogenomic signatures after exposure to idarubicin in the rat


TSA628-DrugMatrix - Toxicogenomic signatures of Heart after exposure to idarubicin (.625 mg/kg, 1 days) in the rat


TSA629-DrugMatrix - Toxicogenomic signatures of Heart after exposure to idarubicin (.625 mg/kg, 5 days) in the rat


TSA630-DrugMatrix - Toxicogenomic signatures of Heart after exposure to idarubicin (.625 mg/kg, 3 days) in the rat


TSF628-idarubicin


1 subfactor(s)
TSF629-idarubicin


1 subfactor(s)
TSF630-idarubicin


1 subfactor(s)
TSS628-DrugMatrix - Toxicogenomic signatures of Heart after exposure to idarubicin (.625 mg/kg, 1 days) in the rat


TSS629-DrugMatrix - Toxicogenomic signatures of Heart after exposure to idarubicin (.625 mg/kg, 5 days) in the rat


TSS630-DrugMatrix - Toxicogenomic signatures of Heart after exposure to idarubicin (.625 mg/kg, 3 days) in the rat



TSP160 - DrugMatrix - Toxicogenomic signatures after exposure to idarubicin in the rat Public


DrugMatrix is the scientific communities' largest molecular toxicology reference database and informatics system. DrugMatrix is populated with the comprehensive results of thousands of highly controlled and standardized toxicological experiments in which rats or primary rat hepatocytes were systematically treated with therapeutic, industrial, and environmental chemicals at both non-toxic and toxic doses.

Interventional Experimental design


No experimental design provided

Results


No results provided